Exploring Treatment Options for HER2 Positive Metastatic Breast Cancer

Exploring various treatment options from first-line therapies like DHP and THP to second-line options including TDM1 and trastusumab direct secan with a focus on side effects and efficacy. The chapter also touches on third-line treatments like Tucatinib, trastusumab with lapatinib, and the significance of personalized treatment selection based on patient needs.